Jennison Associates LLC Verona Pharma PLC Transaction History
Jennison Associates LLC
- $162 Billion
- Q4 2024
A detailed history of Jennison Associates LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Jennison Associates LLC holds 1,889,542 shares of VRNA stock, worth $109 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,889,542
Previous 1,740,886
8.54%
Holding current value
$109 Million
Previous $50.1 Million
75.2%
% of portfolio
0.05%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding VRNA
# of Institutions
225Shares Held
67.7MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$370 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$323 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$196 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$181 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$181 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...